Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin

Journal of Neurochemistry

Volumn 69, Issue 1, 1997, Pages 214-222

  Menon, Krishna Kumar ^a   Piddlesden, Sara J ^b   Bernard, Claude C A ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Antibodies; Calcium activated neutral protease; Myelin basic protein degradation

Indexed keywords

AUTOANTIBODY; GALACTOSYLCERAMIDE; GLYCOPROTEIN; MONOCLONAL ANTIBODY; MYELIN BASIC PROTEIN; MYELIN PROTEIN; NEUTRAL PROTEINASE;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DEMYELINATION; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0031008342     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69010214.x     Document Type: Article

References (55)

1. Abo S., Bernard C. C. A., Webb M., Johns T. G., Alafaci A., Ward L. D., Simpson R. J., and Kerlero de Rosbo N. (1993) Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies. Biochem. Mol. Biol. Int. 30, 945-958.
2. Banik N. L., Hogan E. L., Jenkins M. G., McDonald J. K., McAlhaney W. W., and Sostek M. B. (1983) Purification of a calcium activated neutral proteinase from bovine brain. Neurochem. Res. 8, 1389-1405.
3. Banik N. L., Hogan E. L., and McAlhaney W. W. (1984) A role for calcium and activation of neutral proteinase in myelinolysis?, in Experimental Allergic Encephalomyelitis: A Useful Model for Multiple Sclerosis? (Alvord E. C., Kies M. W., and Suckling A. J., eds), pp. 145-152. Alan R. Liss, New York.
4. 2+-activated neutral proteinase associated with purified myelin of rat CNS. J. Neurochem. 45, 581-588.
5. Ben-Nun A., Wekerle H., and Cohen I. R. (1981) The rapid isolation of clonable antigen specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 11, 195-199.
6. Bernard C. C. A., Randell V. B., Horvath L., Carnegie P. R., and Mackay I. R. (1981) Antibodies to myelin basic protein in extracts of multiple sclerosis brain. Immunology 43, 447-457.
7. Bernard C. C. A., Carnegie P. R., and Mackay I. R. (1983) Immunoregulatory mechanism in experimental autoimmune encephalomyelitis and multiple sclerosis, in Multiple Sclerosis (Hallpike J. F., Adams C. W., and Tourtellotte W. W., eds), pp. 479-511. Chapman and Hall, London.
8. Bernard C. C. A., Johns T. G., Slavin A. J. C., Ichikawa M., Ewing C., Liu J., and Bettadapura J. (1997) Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis. J. Mol. Med. 75, 77-88.
9. Brosnan C. F., Cammer W., Traugott U., Norton W. T., and Raine C. S. (1988) Myelin antigens and demyelination, in NATO Advanced Research Workshop: Multidisciplinary Approach to Myelin Diseases (Serlupi Crescenzi G., ed), pp. 207-218. Plenum, London.
10. Brunner C., Lassmann H., Waehneldt T. V., Matthieu J.-M., and Linington C. (1989) Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2′,3′-cyclic nucleotide 3′-phosphodiesterase in the CNS of adult rats. J. Neurochem. 52, 296-304.
11. Burger D., Steck A. J., Bernard C. C. A., and Kerlero De Rosbo N. (1993) Human myelin/oligodendrocyte glycoprotein: a new member of the L2/HNK-1 family. J. Neurochem. 61, 1822-1827.
12. Carnegie P. R., Dowse C. A., and Linthicum D. S. (1983) Antigenic determinant recognised by a monoclonal antibody to human myelin basic protein. J. Neuroimmunol. 5, 125-134.
13. Chantry A., Gregson N. A., and Glynn P. (1989) A novel metalloproteinase associated with brain myelin membranes. Isolation and characterization. J. Biol. Chem. 264, 21603-21607.
14. Cuzner M. L., Bernard R. O., MacGregor B. J. L., Borshell N. J., and Davison A. N. (1976) Myelin composition in acute and chronic multiple sclerosis in relation to cerebral lysosomal activity. J. Neurol. Sci. 29, 323-334.
15. Cyong C. J., Witkin S. S., Rieger B., Barbarese R., Good R. A., and Day N. K. (1982) Antibody-independent complement activation by myelin via the classical pathway. J. Exp. Med. 155, 587-598.
16. Dyer C. A. (1993) Novel oligodendrocyte transmembrane signaling systems: investigations utilizing antibodies as ligands. Mol. Neurobiol. 7, 1-22.
17. Dyer C. A. and Matthieu J.-M. (1994) Antibodies to myelin/oligodendrocyte-specific protein and myelin/oligodendrocyte glycoprotein signal distinct changes in the organization of cultured oligodendroglial membrane sheets. J. Neurochem. 62, 777-787.
18. Earl C., Chantry A., Mohammad N., and Glynn P. (1988) Zinc ions stabilise the association of basic protein with brain myelin membranes. J. Neurochem. 51, 718-724.
19. Einstein E. R., Csejtey J., and Dalal K. B. (1972) Proteolytic activity and basic protein loss in and around multiple sclerosis plaques: combined biochemical and histochemical observations. J. Neurochem. 19, 653-662.
20. Glynn P. and Linington C. (1989) Cellular and molecular mechanisms of autoimmune demyelination in the central nervous system. Crit. Rev. Neurobiol. 4, 367-385.
21. Glynn P., Chantry A., Groome N., and Cuzner M. L. (1987) Basic protein dissociating from myelin membranes at physiological ionic strength and pH is cleaved into three major fragments. J. Neurochem. 48, 752-759.
22. Johns T. G., Kerlero de Rosbo N., Menon K. K., Abo S., Gonzales M. F., and Bernard C. C. A. (1995) Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J. Immunol. 154, 5536-5541.
23. Kerlero de Rosbo N. and Bernard C. C. A. (1989) Multiple sclerosis brain immunoglobulins stimulate myelin basic protein degradation in human myelin: a new cause of demyelination. J. Neurochem. 53, 513-518.
24. Kerlero de Rosbo N., Carnegie P. R., Bernard C. C. A., and Linthicum D. S. (1984) Detection of various forms of brain myelin basic protein in vertebrates by electroimmunoblotting. Neurochem. Res. 9, 1359-1369.
25. Kerlero de Rosbo N., Carnegie P. R., and Bernard C. C. A. (1986) Quantitative electroimmunoblotting study of the calcium-activated neutral protease in human myelin. J. Neurochem. 47, 1007-1012.
26. Kerlero de Rosbo N., Jago M. V., Carnegie P. R., and Bernard C. C. A. (1987) Correlation of the onset of experimental autoimmune encephalomyelitis-like clinical signs with oedema of the spinal cord in tunicamycin-poisoned rats. J. Neurol. Sci. 78, 281-294.
27. Kerlero de Rosbo N., Honegger P., Lassmann H., and Matthieu J.-M. (1990) Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein. J. Neurochem. 55, 583-587.
28. Kerlero de Rosbo N., Tsang S., and Bernard C. C. A. (1991) Comparative study of myelin basic protein isoforms in developing vertebrate central nervous system: absence of 21.5 and 20.2 kilodalton myelin basic proteins in chicken may point to their importance in mammalian myelinogenesis. Dev. Neurosci. 13, 34-40.
29. Kerlero de Rosbo N., Milo R., Lees M. B., Burger D., Bernard C. C. A., and Ben Nun A. (1993) Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J. Clin. Invest. 92, 2602-2608.
30. 4. Nature 227, 680-685.
31. Lebar R., Vincent C., and Fischer-Le Boubennec E. (1979) Studies on autoimmune encephalomyelitis in the guinea pig. III. A com parative study of two autoantigens of central nervous system myelin. J. Neurochem. 32, 1451-1460.
32. Lees M. B. and Bizzozero O. A. (1992) Structure and acylation of proteolipid protein, in Myelin: Biology and Chemistry (Martenson R. E., ed), pp. 237-255. CRC Press, Boca Raton, Florida.
33. Linington C., Webb M., and Woodhams P. L. (1984) A novel myelin associated glycoprotein defined by a mouse monoclonal antibody. J. Neuroimmunol. 6, 387-396.
34. Linington C., Morgan B. P., Scolding N. J., Wilkins P., Piddlesden S., and Compston D. A. S. (1989) The role of complement in the pathogenesis of EAE. Brain 112, 895-911.
35. Liu W. T., Vanguri P., and Shin M. L. (1983) Studies on demyelination in vitro: the requirement of membrane attack components of complement system. J. Immunol. 131, 778-782.
36. Luis A. D., Justin T. R., Fred E. N., Labib R. S., Patel H. P., Mutasim D. F., and Anhalt G. J. (1986) Human pemphigus autoantibodies are pathogenic to squamous epithelium. Ann. NY Acad. Sci. 475, 181-191.
37. 2+ -activated neutral protease from calf brain. J. Biol. Chem. 258, 8955-8962.
38. Norton W. T. and Poduslo S. E. (1973) Myelination in rat brain: method of myelin isolation. J. Neurochem. 21, 749-757.
39. Orazio N. E., Hays A. P., Latov N., Perman G., Golier J., Shy M. E., and Freddo L. (1984) Specificity of mouse and human monoclonal antibodies to myelin associated glycoprotein. Neurology 34, 1336-1342.
40. Ozawa K., Saida T., Nishitani H., and Kameyama M. (1989) In vivo CNS demyelination. Neuropathology 77, 621-628.
41. Piddlesden S. J., Lassmann H., Zimprich F., Morgan B. P., and Linington C. (1993) The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement. Am. J. Pathol. 143, 555-564.
42. Prineas J. W. (1985) The neuropathology of multiple sclerosis, in Handbook of Clinical Neurology, Vol. 3: Demyelinating Diseases (Vinken P. J., Bruyn G. W., and Klawans H. L., eds), pp. 213-257. Elsevier Science, New York.
43. Raine C. S. (1994) The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion. Ann. Neurol. 36, 61-72.
44. Sato S., Quarles R. H., and Brady R. O. (1982) Susceptibility of myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain. J. Neurochem. 39, 97-105.
45. Sato S., Quarles R. H., Brady R. O., and Tourtellotte W. W. (1984) Elevated neutral proteinase activity in myelin from multiple sclerosis brain. Ann. Neurol. 15, 264-267.
46. Schluesener H. J., Sobel R. A., Linington C., and Weiner H. L. (1987) A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J. Immunol. 139, 4016-4021.
47. Schreiber A. B., Lax I., Yarden Y., Eshhar Z., and Schlessinger J. (1981) Monoclonal antibodies against receptor for epidermal growth factor induce early and delayed effects of epidermal growth factor. Proc. Natl. Acad. Sci. USA 78, 7535-7539.
48. Singer K. H., Hashimoto K., Jensen P. J., Morioka S., and Lazarus G. S. (1985) Pathogenesis of autoimmunity in pemphigus. Annu. Rev. Immunol. 3, 87-108.
49. Singh I. and Singh A. K. (1983) Degradation of myelin proteins by brain endogenous neutral protease. Neurosci. Lett. 39, 77-82.
50. Slavin A. J., Johns T. G., Orian J. M., and Bernard C. C. A. (1997) Regulation of myelin oligodendrocyte glycoprotein in different species throughout development. Dev. Neurosci. 19, 69-78.
51. Stoffel W., Hillen H., and Giersiefon H. (1984) Structure and molecular arrangement of proteolipid protein of central nervous system myelin. Proc. Natl. Acad. Sci. USA 81, 5012-5016.
52. Tabira T. and Kira J.-I. (1992) Strain and species differences of encephalitogenic determinants of myelin basic protein and proteolipid apoprotein, in Myelin: Biology and Chemistry (Martenson R. E., ed), pp. 783-789. CRC Press, Boca Raton, Florida.
53. Tsubata T. and Takahashi K. (1989) Limited proteolysis of bovine myelin basic protein by calcium-dependent proteinase from bovine spinal cord. J. Biochem, (Tokyo) 105, 23-28.
54. 2+-dependent protein kinase preferentially phosphorylates serine-115 of bovine myelin basic protein. J. Neurochem. 43, 1257-1264.
55. Walsh M. J. and Tourtellotte W. W. (1983) The cerebrospinal fluid in multiple sclerosis, in Multiple Sclerosis (Hallpike J. F., Adams C. W., and Tourtellotte W. W., eds), pp. 275-358. Chapman and Hall, London.